BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/28/2022 12:37:03 PM | Browse: 602 | Download: 1550
 |
Received |
|
2022-05-10 13:19 |
|
Peer-Review Started |
|
2022-05-10 13:21 |
|
First Decision by Editorial Office Director |
|
2022-08-20 01:08 |
|
Return for Revision |
|
2022-08-20 01:08 |
|
Revised |
|
2022-09-08 10:50 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-10-10 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-10-10 14:52 |
|
Articles in Press |
|
2022-10-10 14:52 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-10-12 02:56 |
|
Publish the Manuscript Online |
|
2022-10-28 12:37 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Guo-Qing Yin, Ke-Ping Chen and Xiao-Chun Gu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guo-Qing Yin, MD, PhD, Chief Doctor, Chief Physician, Center of Hepatology, Zhong-Da Hospital, Southeast University, No. 87 Dingjiaqiao, Nanjing 210009 , Jiangsu Province, China. yingq62@sina.com |
| Key Words |
Hepatitis B virus; Chronic; Functional cure; Heterogeneity; Immunity; Immune control; Interferon-α; Retreatment |
| Core Tip |
Hepatitis B virus (HBV)-specific immune control is characterized by distinct phenotypical and functional profiles. Owing to the negative feedback associated with all immune responses in an infected host, immunomodulators regulating a single immune pathway are unlikely to fully restore antiviral immunity. Interferon-α (IFN-α) treatment was shown to simultaneously affect multiple immune pathways and various immune cell populations in the host and integrate signals toward improving HBV-specific immune control. In addition, IFN-α retreatment was shown to improved functional cure rates, indicating that could gradually enhance the overall immune control. |
| Publish Date |
2022-10-28 12:37 |
| Citation |
Yin GQ, Chen KP, Gu XC. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. World J Gastroenterol 2022; 28(40): 5784-5800 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i40/5784.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i40.5784 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
